Company Search:
Advanced Search
Sponsored Links
Editas Medicine Inc Company Snapshot
Editas Medicine Inc operates within the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Editas Medicine Inc with three other companies in this sector in UNITED STATES : Acceleron Pharma Inc (2020 sales of $92.52 million of which 100% was Bio-pharmaceutical), Twist Bioscience Corp ($90.10 million of which 49% was NGS tools), and Agenus Incorporation ($88.17 million of which 100% was Immuno-oncology).

Sales Analysis. During the first quarter of 2021, sales at Editas Medicine Inc totalled $6.50 million. This is an increase of 13.6% from the $5.72 million in sales at the company during the first quarter of 2020. Sales increased substantially in 2020: During the year ended December of 2020, sales at Editas Medicine Inc were $90.73 million. This is an increase of 341.9% versus 2019, when the company's sales were $20.53 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Editas Medicine Inc
  Stock Performance Chart for Editas Medicine Inc
  Stock Data: Recent Stock Performance:
  Current Price (6/18/2021): 35.88
(Figures in U.S. Dollars)
1 Week -4.1%   13 Weeks 8.0%  
4 Weeks -20.3%   52 Weeks 11.6%  
Editas Medicine Inc Key Data:
  Ticker: EDIT Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2020 Sales 90,732,000
(Year Ending Jan 2021).
Employees: 235
  Currency: U.S. Dollars Market Cap: 2,420,917,426
  Fiscal Yr Ends: December Shares Outstanding: 67,472,615
  Share Type: common Closely Held Shares: 853,468
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.